Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Adherex to discuss development of sodium thiosulfate with FDA advisory committee

Oct. 10, 2011

BAY-1017858 shows promise in vitro and in vivo

Oct. 10, 2011

AXL-1717 benefits patients with advanced-stage NSCLC in phase I trial

Oct. 10, 2011

Millennium withdraws sNDA for Velcade

Oct. 7, 2011

BioCancell recruits first patients in BC-819 pancreatic cancer study

Oct. 7, 2011

Enrollment complete in Peregrine phase II NSCLC trial

Oct. 7, 2011

Pfizer licenses neratinib to Puma Biotechnology

Oct. 7, 2011

New PLK1 inhibitors developed

Oct. 7, 2011

Bavarian Nordic gains rights to NCI anticancer vaccine candidate

Oct. 7, 2011

Millennium Pharmaceuticals discloses updated results from ongoing phase I trial of MLN-9708

Oct. 7, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...